Vivanza Biosciences Ltd
VIVANZAVivanza Biosciences Ltd
VIVANZA
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 32.69 | 8.79 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.48 | 5.11 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Vivanza Biosciences is engaged in the business of trading of pharmaceutical products.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 3.52 | 6.44 | 2.66 | 10.19 | 10.40 | 11.23 | 18.29 | 31.14 | ||||||||||
Raw Materials | 0.00 | 0.00 | 4.88 | 6.00 | 2.08 | 8.26 | 8.84 | 11.43 | 16.55 | 29.48 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 0.00 | 0.00 | 0.38 | 0.09 | 0.05 | 0.30 | 0.34 | 0.25 | 0.31 | |||||||||||
| Selling & Administrative Expenses | 0.05 | 0.06 | 0.29 | 0.17 | 0.22 | 0.28 | 0.21 | 0.37 | 0.23 | |||||||||||
| Operating & Other expenses | 0.00 | 0.00 | -1.76 | -0.42 | 0.33 | 1.12 | 0.39 | -1.59 | 0.04 | |||||||||||
EBITDA | -0.05 | -0.06 | -0.27 | 0.60 | -0.02 | 0.23 | 0.62 | 0.77 | 1.16 | 1.66 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | — | ||||||||||
| PBIT | -0.05 | -0.06 | -0.27 | 0.60 | -0.02 | 0.23 | 0.61 | 0.76 | 1.16 | 1.66 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.04 | 0.37 | 0.42 | 0.44 | 0.47 | 0.43 | 0.43 | 0.44 | ||||||||||
| PBT | -0.05 | -0.06 | -0.31 | 0.23 | -0.44 | -0.21 | 0.14 | 0.33 | 0.73 | 1.22 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.05 | 0.00 | 0.12 | 0.12 | ||||||||||
| Net Income | -0.05 | -0.06 | -0.31 | 0.20 | -0.44 | -0.21 | 0.09 | 0.33 | 0.61 | 1.10 | ||||||||||
| EPS | -0.13 | -0.05 | -0.01 | 0.01 | -0.01 | -0.01 | 0.00 | 0.01 | 0.03 | 0.28 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Vivanza Biosciences Ltd | 58.95 | 8.79 | — |
| Sun Pharmaceutical Industries Ltd | 35.09 | 5.01 | 0.93% |
| Cipla Ltd | 35.23 | 4.16 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.37 | 4.14 | 0.69% |
Price Comparison
Compare VIVANZA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
VIVANZA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Vivanza Biosciences consolidated net profit declines 34.62% in the September 2022 quarter
1 year ago•Business Standard
Vivanza Biosciences consolidated net profit rises 23.81% in the September 2021 quarter
2 years ago•Business Standard
Vivanza Biosciences reports consolidated net profit of Rs 0.32 crore in the June 2021 quarter
2 years ago•Business Standard
Vivanza Biosciences reports consolidated net loss of Rs 0.13 crore in the March 2021 quarter
2 years ago•Business Standard
Vivanza Biosciences reports consolidated net profit of Rs 0.17 crore in the December 2020 quarter
2 years ago•Business Standard
Vivanza Biosciences reports standalone net profit of Rs 0.15 crore in the December 2020 quarter
2 years ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 23.22%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 0% to 0.01%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 24.99%, vs industry avg of 9.82%